Biomarkers of endothelial dysfunction are elevated and related to prognosis in chronic heart failure patients with diabetes but not in those without diabetes

C Kistorp, AY Chong, F Gustafsson, S Galatius, I Raymond, J Faber, Gregory Lip, P Hildebrandt

Research output: Contribution to journalArticle

22 Citations (Scopus)

Abstract

BACKGROUND: Biomarkers of endothelial dysfunction, such as soluble E-selectin, and von Willebrand factor (vWf) are elevated in patients with chronic heart failure (CHF). The impact of diabetes mellitus (DM) on these biomarkers, and their relation to prognosis remains unknown. AIMS: to investigate the impact of DM on plasma levels and the prognostic value of E-selectin and vWf in patients with CHF. METHODS AND RESULTS: Plasma levels of E-selectin and vWf were measured in 195 CHF patients with (n=48, 24.5%), and without DM, and in 116 age-matched healthy controls. Compared with controls, median plasma E-selectin levels were higher in CHF patients with DM (P=0.012), but not in CHF patients without DM (P=0.45); vWf levels were also higher in CHF patients with DM (P
Original languageEnglish
Pages (from-to)380-7
Number of pages8
JournalEuropean Journal of Heart Failure
Volume10
Issue number4
DOIs
Publication statusPublished - 1 Apr 2008

Fingerprint

Dive into the research topics of 'Biomarkers of endothelial dysfunction are elevated and related to prognosis in chronic heart failure patients with diabetes but not in those without diabetes'. Together they form a unique fingerprint.

Cite this